ASD vs. XMAG

Last updated Jul 1, 2026

ASD (Defiance Autism Impact ETF) and XMAG (Defiance Large Cap ex-Mag 7 ETF) are both exchange-traded funds - ASD is a Health & Biotech Equities fund managed by Defiance, while XMAG is a Large Cap Blend Equities fund tracking the BITA US 500 ex Magnificent 7 Index. At a 0.15 correlation, their price movements are largely independent. ASD charges 0.79%/yr vs 0.35%/yr for XMAG.

Performance

ASD vs. XMAG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Defiance Autism Impact ETF (ASD) and Defiance Large Cap ex-Mag 7 ETF (XMAG). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

ASD

• 1D: 0.51%
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

XMAG

• 1D: 0.75%
• 1M: 3.90%
• YTD: 15.55%
• 6M: 15.04%
• 1Y: 23.59%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

ASD vs. XMAG - Yearly Performance Comparison

	2026 (YTD)
ASD Defiance Autism Impact ETF	9.64%
XMAG Defiance Large Cap ex-Mag 7 ETF	3.37%

Correlation

The correlation between ASD and XMAG is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (All Time) Calculated using the full available price history since Jun 2, 2026	0.15

Return for Risk

ASD vs. XMAG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ASD

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

XMAG

XMAG Risk / Return Rank: 76
XMAG Sharpe Ratio Rank: 75
XMAG Sortino Ratio Rank: 77
XMAG Omega Ratio Rank: 71
XMAG Calmar Ratio Rank: 75
XMAG Martin Ratio Rank: 83

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ASD vs. XMAG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Defiance Autism Impact ETF (ASD) and Defiance Large Cap ex-Mag 7 ETF (XMAG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ASD	XMAG	Difference
Sharpe ratio: Return per unit of total volatility	—	2.03	—
Sortino ratio: Return per unit of downside risk	—	2.90	—
Omega ratio: Gain probability vs. loss probability	—	1.36	—
Calmar ratio: Return relative to maximum drawdown	—	3.25	—
Martin ratio: Return relative to average drawdown	—	14.28	—

Drawdowns

ASD vs. XMAG - Drawdown Comparison

The maximum ASD drawdown since its inception was -2.42%, smaller than the maximum XMAG drawdown of -16.17%. Use the drawdown chart below to compare losses from any high point for ASD and XMAG.

Drawdown Indicators

	ASD	XMAG	Difference
Max Drawdown Largest peak-to-trough decline	-2.42%	-16.17%	+13.75%
Max Drawdown (1Y) Largest decline over 1 year	—	-7.29%	—
Current Drawdown Current decline from peak	0.00%	0.00%	0.00%
Average Drawdown Average peak-to-trough decline	-0.78%	-2.07%	+1.29%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	1.66%	—

Volatility

Volatility by Period

	ASD	XMAG	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	4.53%	—
Volatility (6M) Calculated over the trailing 6-month period	—	9.29%	—
Volatility (1Y) Calculated over the trailing 1-year period	17.25%	11.70%	+5.55%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	17.25%	15.15%	+2.10%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	17.25%	15.15%	+2.10%

ASD vs. XMAG - Expense Ratio Comparison

ASD has a 0.79% expense ratio, which is higher than XMAG's 0.35% expense ratio.

Dividends

ASD vs. XMAG - Dividend Comparison

ASD's dividend yield for the trailing twelve months is around 0.02%, less than XMAG's 0.45% yield.

Position	TTM	2025	2024
ASD Defiance Autism Impact ETF	0.02%	0.00%	0.00%
XMAG Defiance Large Cap ex-Mag 7 ETF	0.45%	0.51%	0.24%

Frequently Asked Questions

Can I hold both ASD and XMAG in my portfolio?

ASD and XMAG have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, ASD or XMAG?

On fees, XMAG is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, ASD or XMAG?

XMAG is cheaper with a 0.35% expense ratio, compared with 0.79% for ASD.

Which ETF pays a higher dividend yield, ASD or XMAG?

XMAG has the higher dividend yield at 0.45%, compared with 0.02% for ASD.

What is the main difference between ASD and XMAG?

ASD is categorized as Health & Biotech Equities, while XMAG is Large Cap Blend Equities. Their fees differ too: 0.79% for ASD and 0.35% for XMAG.